SKI Market

Indian Indices

Nifty

25,839.65 -120.90
(-0.47%)

Sensex

84,666.28 -436.41
( -0.51%)

Bank Nifty

59,222.35 -16.20
( -0.03%)

Nifty IT

38,130.60 -460.10
( -1.19%)

Global Indices

Nasdaq

47,765.34 -210.65
(-0.44%)

Dow Jones

6,868.55 -22.85
(-0.33%)

Hang Seng

50,689.00 107.06
(0.21%)

Nikkei 225

9,640.58 -26.43
(-0.27%)

Forex

USD-INR

89.90 -0.09
(-0.10%)

EUR-INR

104.66 -0.26
(-0.25%)

GBP-INR

119.79 -0.26
(-0.22%)

JPY-INR

0.58 0.00
(-0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

BSE Sensex Sixty 65:35

Industry : Stock Exchanges

BSE Code

ISIN Demat

Book Value()

1191

N.A

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

EPS(TTM)

Face Value()

Div & Yield %

100

Back

Shree Ganesh Biotech India standalone net profit declines 96.88% in the September 2025 quarter

Nov 08,2025

Net profit of Shree Ganesh Biotech India declined 96.88% to Rs 0.01 crore in the quarter ended September 2025 as against Rs 0.32 crore during the previous quarter ended September 2024. Sales declined 61.11% to Rs 0.77 crore in the quarter ended September 2025 as against Rs 1.98 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.77	1.98	-61
OPM %	-51.95	1.01	-
PBDT	0.01	0.32	-97
PBT	0.01	0.32	-97
NP	0.01	0.32	-97

25,839.65 -120.90 (-0.47%)

84,666.28 -436.41 ( -0.51%)

59,222.35 -16.20 ( -0.03%)

38,130.60 -460.10 ( -1.19%)

47,765.34 -210.65 (-0.44%)

6,868.55 -22.85 (-0.33%)

50,689.00 107.06 (0.21%)

9,640.58 -26.43 (-0.27%)

89.90 -0.09 (-0.10%)

104.66 -0.26 (-0.25%)

119.79 -0.26 (-0.22%)

0.58 0.00 (-0.32%)